Try our Advanced Search for more refined results
Alvogen Group Inc.
-
Discovery | Filed: May 17, 2024 | Entered: May 17, 2024 In Re: Ozempic (Semaglutide) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Opening Expert Report of Virginia W. Cornish, Ph.D. Regarding Invalidity of U.S. Patent 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly)
-
Discovery | Filed: May 17, 2024 | Entered: May 17, 2024 Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Opening Expert Report of Virginia W. Cornish, Ph.D. Regarding Invalidity of U.S. Patent 8,129,343 filed by Sun Pharmaceutical Industries Ltd., Sun Pharmaceuticals Industries Inc., Sun Pharmaceutical Industries Inc..(Farnan, Kelly)
-
Motion | Filed: May 16, 2024 | Entered: May 16, 2024 In Re: National Prescription Opiate Litigation
P.I.: Other | Ohio Northern
Protective Order
Joint Motion for protective order filed by Defendant Express Scripts Inc., MDL Notice Only OptumRx, Inc.. (Attachments: # 1 Declaration of Jonathan G. Cooper, # 2 Exhibit A to Cooper Declaration, # 3 Exhibit B to Cooper Declaration, # 4 Exhibit C to Cooper Declaration, # 5 Exhibit D to Cooper Declaration)(Cooper, Jonathan)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login